Log in
Obstetrics and Gynecology · Gynecology

Treatment of ovarian tumors

*Ovariectomia*

Despite the topic's title, successful management of adnexal neoplasms is impossible without precise verification of the process. The foundation of patient management is a comprehensive diagnostic workup, including sonography with blood flow assessment, tomography, and determination of specific antigens to rule out malignant growth.

Resistance indexRI < 0.4 on Doppler sonography indicates malignancy of the process.
CA-125 tumor markerNormal value up to 35 IU/mL; not used for primary screening due to low specificity.
LaparoscopyAllows tissue biopsy and collection of peritoneal fluid for cytology.
Specific signFirm, painless "spikes" behind the uterus upon bimanual examination.
4 min readFor medical studentsUpdated Sep 25, 2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Risk factors and physical examination

Special attention during history taking is paid to patients from high-risk groups. Women presenting with the following factors require careful monitoring:

  • Impaired normal ovarian function and fertility issues.
  • Prolonged follow-up due to tubo-ovarian inflammatory masses.
  • Recurrent endometrial hyperplastic processes, especially in the postmenopausal period.
  • History of surgical interventions for benign adnexal tumors.

During a bimanual gynecological examination, malignant neoplasms are most often bilateral. On palpation, they are defined as firm, nodular masses of oval or irregular shape, with sharply limited or completely absent mobility. A specific physical sign of malignancy is the so-called "spikes" — painless firm growths posterior to the uterus that project into the rectal lumen. As a rule, the tumor process is accompanied by significant fluid accumulation — ascites. A rectovaginal examination is mandatory to accurately assess tumor invasion into the parametrial and pararectal tissue.

Sonography and blood flow assessment

The gold standard for primary imaging is high-resolution transvaginal sonography (TVS) supplemented with color Doppler mapping (CDM).

Sonographic criteria of malignancy include:

  • Significant dimensions of the space-occupying lesion (often bilateral).
  • Irregular shape and thickened, uneven capsule.
  • Presence of multiple papillary growths within the cyst and internal septa of varying thickness.
  • Accumulation of free fluid (ascites) in the abdominal cavity and small pelvis.

The use of CDM and spectral Doppler sonography makes it possible to detect zones of neovascularization — numerous randomly distributed vessels both in the periphery and in the central structures of the tumor (in the septa and vegetations). A key hemodynamic marker of malignancy is low vascular resistance: the resistance index (RI) drops below 0.4 (calculated by measuring systolic and diastolic blood flow).

Three-dimensional sonography (3D US) provides the opportunity to study in detail the spatial relief of the inner capsule wall and accurately determine the volume of the mural solid component. Isolated 3D reconstruction of the vascular bed (three-dimensional angiography) clearly demonstrates a pathological tortuous network with numerous anastomoses, which reliably distinguishes cancer from a benign process.

Test your knowledge on this topicTasks from the "Obstetrics and Gynecology" course bank — immediate answers and explanations.

Tomography, laparoscopy, and tumor markers

To clarify the diagnosis and assess the extent of the process, X-ray computed tomography (CT) and magnetic resonance imaging (MRI) are used. On tomograms, malignant tumors appear as space-occupying structures with nodular contours, inhomogeneous internal density (a combination of fluid and soft tissues), and a thickened capsule. A specific task of CT is the visualization of clear boundaries between the intestine, uterus, and urinary bladder to detect adhesions in the small pelvis.

Final morphological verification of the tumor histotype is achieved using laparoscopy. During the endoscopic intervention, the surgeon performs a targeted tissue biopsy and collects peritoneal fluid for cytological analysis.

Laboratory diagnostics rely on the study of serum tumor-associated antigens (CA-125, CA-19.9, CA-72.4). The level of CA-125 (normal up to 35 IU/mL) is elevated in 78–100% of patients with ovarian cancer. However, due to low specificity in early stages, this marker cannot be used as a screening test. Its main clinical value is monitoring the patient's condition and evaluating the effectiveness of ongoing treatment.

The complete examination algorithm necessarily includes ultrasound of the abdominal cavity, thyroid, and mammary glands, mammography, as well as endoscopic and radiological studies of the gastrointestinal tract (gastroscopy, colonoscopy, barium enema). This complex allows for an accurate diagnosis in 80–85% of cases. For the remaining patients, only diagnostic laparotomy provides a definitive answer.

Briefly: answers to topical questions

What stages and types of surgical interventions for malignant ovarian tumors are performed during laparotomy?

During laparotomy for malignant ovarian tumors, radical, fertility-sparing, and staging surgical interventions are performed depending on the stage of the disease.

Depending on the stage, the following are performed:

  • Stage I — limited (fertility-sparing) operations are permissible.
  • Stage II and early stages — radical comprehensive staging laparotomy is indicated.

Types of interventions performed:

  • Extirpation of the uterus with appendages (panhysterectomy) — the standard volume of radical surgery.
  • Extirpation of the greater omentum (omentectomy) — mandatory removal to prevent the development of ascites.
  • Transabdominal hysterectomy with bilateral salpingo-oophorectomy (TAH/BSO) — performed as part of a comprehensive staging laparotomy.
  • Surgical staging procedures — include collection of peritoneal fluid or washings, revision of para-aortic lymph nodes, and biopsy of the peritoneum and diaphragm.
How to memorize

To memorize ultrasound signs of malignancy, use the acronym PANK: Septa (uneven), Ascites, Neovascularization (RI < 0.4), Capsule (thick).

Class and exam questions

Can CA-125 be used for mass screening for ovarian cancer?

No, in early forms of cancer, its specificity is low. The marker is used to monitor treatment efficacy and subsequent patient follow-up.

Why is a rectovaginal examination mandatory?

It is necessary to assess the invasion of the cancerous process into the pararectal and parametrial tissue.

What blood flow indicator on ultrasound indicates malignancy?

The key hemodynamic sign is low blood flow resistance — the resistance index (RI) is less than 0.4.

Something unclear? Ask the AIThe AI tutor has reviewed the material on "Treatment of Ovarian Tumors" and will explain it in simple terms.

What else to study on this topic

  • Ultrasound machine settings for capturing low-velocity blood flow (WMF, PRF).
  • Three-dimensional reconstruction of the vascular bed (3D angiography) and evaluation of neoangiogenesis.
  • The role of computed tomography in detecting adhesions in the small pelvis.
  • Complete examination algorithm: why mammography and GI endoscopy are needed in suspected ovarian cancer.

Master the entire topic in the "Obstetrics and Gynecology" course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Treatment of Ovarian Tumors" and 973 more pages of the subject
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 21 video lessons on the subject

Other topics in the "Gynecology" section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.